Cardiac and Metabolic Disorder Sterile Injectable Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
Injectable drug delivery is the mode of administration of a drug into a patient directly through the bloodstream. As the drug has to be injected directly into the bloodstream, it needs to be sterile. Sterile injectable drugs are usually formulated in liquid form. They allow the transport of the drug directly into the body through circulating blood, even though they may be designed to transport the drug to a specific part of the body. Manufacturing of sterile injectable drugs in a complex process and involves high initial investment and operating costs. This has allowed the entry of only a few major players in the sterile injectable market.
Rise in chronic diseases across the world, especially cardio vascular and metabolic diseases such as diabetes; emphasis on research and development by drug manufacturers; faster approval of sterile injectables by the FDA; coupled with short approval timelines for new drug for the treatment of cancer are the key factors boosting the demand for sterile injectables in the global market. Rise in usage of biologics and development of monoclonal antibodies also contribute to the growth of the sterile injectable drugs market. Manufacturing, expansion, and handling cost of sterile injectable drugs is higher than that of conventional dosage forms as the former needs to be sterilized before or during manufacturing. Furthermore, in the U.S., the FDA has imposed stringent regulations on the facilities and equipment involved in the manufacturing of sterile injectable drugs, as these are highly toxic and infectious. Therefore, a high level of quality and care is essential in the manufacturing, packaging, storage, and distribution of sterile injectable drugs. This has led to shortage in the supply of sterile injectables in the U.S., developing higher risk in case of cardiac emergencies.
The global cardiac and metabolic disorder sterile injectable market can be classified on the basis of categories such as type, drug class, and distribution channel. Based on product type, the cardiac and metabolic disorder sterile injectable drugs market can be divided into small and large molecules. On the basis of drug class, the cardiac and metabolic disorder sterile injectable market can be segmented into monoclonal antibodies, cytokines, peptide hormones, vaccines, peptide antibiotics, insulin, blood factors, immunoglobulin, and others. In terms of distribution channel, the cardiac and metabolic disorder sterile injectable market can be bifurcated into hospital pharmacy, retail pharmacy, and e-commerce. Based on type of sterile injectable drug, large molecule drugs remain the key contributor of the global cardiac and metabolic disorder sterile injectable market. Large molecule drugs are used in chronic diseases where immediate response is desired, especially in heart congestion cases. Rise in preference for large molecule drugs over conventional ones is expected to drive the large molecule sterile injectable segment during the forecast period. Based on drug class, monoclonal antibodies held the dominant share of the cardiac and metabolic disorder sterile injectable market, followed by the vaccines and insulin segments. In terms of distribution channel, the hospitals segment constituted the leading share of the cardiac and metabolic disorder sterile injectable market.
Based on geography, the cardiac and metabolic disorder sterile injectable market can be segmented into North America, Europe, Asia, Latin America, and Rest of World. Among these, North America and Europe accounted for the dominant share of the cardiac and metabolic disorder sterile injectable market, followed by Asia, Latin America, and Middle East & Africa. The U.S. dominated the sterile injectable drugs market in North America due to factors such as technological advancements, extensive R&D, and rise in healthcare awareness regarding the treatment and management of chronic diseases in the country. Following the U.S. and Europe, Asia Pacific is anticipated to witness a rapid growth in the cardiac and metabolic disorder sterile injectable market during the forecast period. New product launches, favorable regulations, high number of patients, and rise in awareness are projected to drive the cardiac and metabolic disorder sterile injectable market in Asia during the forecast period.
Key players operating in the sterile injectable drugs market are Baxter International Inc., Sanofi, Pfizer Inc., GlaxoSmithKline plc., AstraZeneca, Gilead, Sciences, Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., and Novo Nordisk A/S.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017